Holen Sie sich die Stockscreener-App
42.54
4.92%
1.995
Handel nachbörslich:
42.63
0.09
+0.21%
Schlusskurs vom Vortag:
$40.55
Offen:
$40.5
24-Stunden-Volumen:
70,986
Relative Volume:
1.58
Marktkapitalisierung:
$299.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.98M
KGV:
-32.28
EPS:
-1.3177
Netto-Cashflow:
$-3.85M
1W Leistung:
+22.24%
1M Leistung:
+65.85%
6M Leistung:
+1.77%
1J Leistung:
+4,112%
1-Tages-Spanne:
$40.05
$44.50
1-Wochen-Bereich:
$34.19
$44.50
52-Wochen-Spanne:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Firmenname
Bright Minds Biosciences Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie DRUG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
42.54 | 287.19M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-13 | Eingeleitet | TD Cowen | Buy |
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-23 | Eingeleitet | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-26 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten
Quantitative breakdown of Bright Minds Biosciences Inc. recent moveBuy Signal & Fast Entry Momentum Alerts - Newser
Analyzing Bright Minds Biosciences Inc. with risk reward ratio chartsEarnings Recap Report & Verified Chart Pattern Trade Signals - Newser
Analyzing Bright Minds Biosciences Inc. with risk reward ratio charts [Portfolio Risk Report]High Yield Stock Recommendations - Newser
How to track smart money flows in Bright Minds Biosciences Inc.Weekly Stock Report & Smart Swing Trading Techniques - Newser
Smart tools for monitoring Bright Minds Biosciences Inc.’s price actionFree Access to Smart Investment Tips - Newser
Using economic indicators to assess Bright Minds Biosciences Inc. potentialTrade Safety Matrix for Conservative Traders - Newser
Chart based exit strategy for Bright Minds Biosciences Inc.Free Weekly Setup With 3x Return Potential - Newser
Bright Minds Biosciences (DRUG) Projected to Post Earnings on Wednesday - Defense World
How Bright Minds Biosciences Inc. stock performs during market volatilityWeekly Chart Watchlist with Trade Guidance - Newser
Full technical analysis of Bright Minds Biosciences Inc. stockSwing Entry Risk Mitigation with Chart Analysis - Newser
Can Bright Minds Biosciences Inc. stock recover from recent declinePredictable Income Summary for Long-Term Trades - Newser
How to build a dashboard for Bright Minds Biosciences Inc. stockRisk-Managed Swing Setup and Signal Analysis - Newser
Bright Minds Biosciences Inc. stock outlook for YEARMomentum Screener with Buy and Sell Areas - Newser
Bright Minds Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowReal-Time Investment Signal Forecast with AI - Newser
Is LIMNW showing signs of accumulationAI Risk Optimized Trade Forecast Planner - Newser
Bright Minds Biosciences Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Consistent Profit Pattern Recognition Tools - Newser
Sentiment analysis tools applied to Bright Minds Biosciences Inc.Free Safe Entry Stock Watch Suggestions - Newser
Will Bright Minds Biosciences Inc. Recover After Recent DeclineInvestment Playbook for Growing Markets Shared - metal.it
Earnings visualization tools for Bright Minds Biosciences Inc.Trading Volume Spike and Reversal Analysis - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyLong-Term Stock Growth Forecast Insights - Newser
Should I hold or sell Bright Minds Biosciences Inc. stock in 2025Unlock daily market insights for better trades - Jammu Links News
What are the technical indicators suggesting about Bright Minds Biosciences Inc.Invest smarter with data-backed trading alerts - Jammu Links News
What institutional investors are buying Bright Minds Biosciences Inc. stockAchieve rapid financial growth with expert picks - Jammu Links News
What analysts say about Bright Minds Biosciences Inc. stockInvest confidently with actionable market data - Jammu Links News
How many analysts rate Bright Minds Biosciences Inc. as a “Buy”Free Stock Chart Pattern Guide - Jammu Links News
When is Bright Minds Biosciences Inc. stock expected to show significant growthHigh-octane investment opportunities await - Jammu Links News
How strong is Bright Minds Biosciences Inc. company’s balance sheetAchieve exceptional returns with expert guidance - Jammu Links News
What catalysts could drive Bright Minds Biosciences Inc. stock higher in 2025Discover market opportunities others miss - Jammu Links News
Why Bright Minds Biosciences Inc. stock attracts strong analyst attentionVolume Based Entry Signal Summary - beatles.ru
Why is Bright Minds Biosciences Inc. stock attracting strong analyst attentionRealize consistent double-digit growth - Jammu Links News
What are analysts’ price targets for Bright Minds Biosciences Inc. in the next 12 monthsFind the best stocks for sustainable growth - Jammu Links News
Technical signs of recovery in Bright Minds Biosciences Inc.Free Investment Plan With Growth Optimization - Newser
What are Bright Minds Biosciences Inc. company’s key revenue driversReal Time Alerts For Fast Growth - Jammu Links News
What is Bright Minds Biosciences Inc. company’s growth strategyExpert Picks Insights For Fast Growth - jammulinksnews.com
New Product Launches: Will They Boost Bright Minds Biosciences Inc. Stock in 2025Controlled Entry Strategy With Safety Analytics - Newser
Finanzdaten der Bright Minds Biosciences Inc-Aktie (DRUG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):